If you need a more accessible version of this website, click this button on the right. Switch to Accessible Site

WARNING

You are using an outdated browser. Please upgrade your browser to improve your experience.

Close [x]

Funded Trials

  • Intermediate to High Grade T-Cell Lymphoma: Funded study enrolling cases in a nationwide clinical trial to evaluate a monoclonal antibody (AT-005) that is conditionally licensed by the USDA to aid in the treatment of dogs with lymphoma. The study is designed to assess the benefit of adding AT-005 toa chemotherapy protocol for dogs with intermediate to high grade T-cell lymphoma. The pet owner will be financially responsible for the initial consultation, blood and urine analysis, and thoracic radiographs. A lymph node biopsy and flow cytometry analysis will be performed at no cost to the owner. Once the dog is confirmed eligible (non-indolent, T-cell lymphoma), rechecks and treatment will be fully funded.

Partially Funded and Other Trials

  • OSA in Greyhounds::  In conjunction with the Greyhound Health and Wellness Program at The Ohio State University, aims to determine if there is a genetic correlation among retired racing greyhounds that develop OSA. Five doses of chemotherapy agent provided free of charge to qualified greyhounds in exchange for a small blood sample.

(Prior to acceptance into any trial, all candidates are required to have a consultation to determine eligibility. The fee for the consultation is the responsibility of the pet owner.)

Call one of our locations for more information.

Go to top of page